Andrew Kawasaki, PhD

 

Dr Kawasaki obtained a PhD in Medicinal Chemistry at University of Michigan, then completed a productive career spanning 25 years in the Biopharmaceutical Industry (Drug Discovery, Research and Development, Bioactive Small Molecules) with tenures at Ionis Pharmaceuticals (formerly Isis Pharmaceuticals) and Arena Pharmaceuticals. Having compiled an extensive publications and patents record, Dr Kawasaki is co-author of 38 peer-reviewed publications and co-inventor on 36 patent applications including 13 granted patents. Also, Dr Kawasaki performed technology feasibility research for the development of novel products and evaluated intellectual property (IP) opportunities.

 

Since joining WCTE, Inc, Dr Kawasaki has intently studied the current biomedical scientific literature on Neurodegenerative Diseases, including Chronic Traumatic Encephalopathy (CTE), Parkinson's disease (PD), Alzheimer's disease (AD), and Amyotrophic Lateral Sclerosis (ALS), suffered by American Football players (active and retired), military personnel, soccer players, and boxers. We strive to take advantage of the state of art advances in the Neurodegenerative Diseases research to develop products to prevent, treat, and cure CTE, PD, AD, and ALS.

​​​

​